Master Files Submission of Pharmaceutical Excipients in China
View more
Clinical Evaluation Report for Products that are Exempt from Clinical Trials
View more
Clinical Evaluation Report for Adopting Overseas Clinical Trials Data
View more
Registration of Imported-to-domestic Products
View more
Clinical Evaluation Report for Adopting Real-world Data
View more
Master Files Submission of Pharmaceutical Excipients in China
View more
Clinical Evaluation Report for Products that are Exempt from Clinical Trials
View more
Clinical Evaluation Report for Adopting Overseas Clinical Trials Data
View more
Registration of Imported-to-domestic Products
View more
Clinical Evaluation Report for Adopting Real-world Data
View more
Company News
A Year of Shared Success: CIRS Japan Successfully Hosts its 1st First Anniversary Celebration and the Global Chemical Regulation Seminar
Oct 24, 2025
From REACH to Resilience – Highlights and Photos from the 2025 Global Chemical Regulations Conference
Sep 30, 2025
CIRS Europe and EPY Announce Strategic Cooperation Agreement
Apr 03, 2025
CIRS Group Korea Selected as an Implementing Agency for the 2025 KCII Overseas Cosmetics Licensing Support Program
Feb 21, 2025
CIRS Japan Formally Established in Tokyo
Jan 22, 2025
CIRS Global Chemical Regulations Conference 2024: A Resounding Success
Oct 23, 2024
CIRS Group Korea Selected as the Executing Agency for Korea Cosmetic Industry Institute (KCII)’s 『2024 Cosmetic Ingredient Safety Evaluation Research Project』
Apr 01, 2024
CIRS Group Korea Selected as the Executing Agency for Korea Chemicals Management Association (KCMA)’s 『2024 Chemical Act and Product Act Small and Medium Business Support Project』
Apr 01, 2024